Literature DB >> 9761510

Low-density lipoprotein subfraction profiles in chronic renal failure.

I Rajman1, L Harper, D McPake, M J Kendall, D C Wheeler.   

Abstract

BACKGROUND: Small low-density lipoprotein (LDL) particle size, a newly recognized risk factor for cardiovascular disease in the general population, is frequently associated with hypertriglyceridaemia, the predominant plasma lipid abnormality present in uraemia.
METHODS: Plasma lipids and LDL subfraction profiles were examined in 33 non-dialysed patients with chronic renal failure (predial), 40 patients on continuous ambulatory peritoneal dialysis (CAPD), 42 haemodialysis patients (HD), 47 renal transplant recipients (RTR), and 44 controls. LDL subfractions separated by gel electrophoresis were scored by densitometric analysis (higher scores indicate profiles comprising smaller particles).
RESULTS: All groups with renal failure had significantly elevated (mean+/-SD) LDL scores (predial 1.36+/-0.6, CAPD 1.71+/-0.9, HD 1.68+/-0.9, RTR 1.92+0.8 vs control 0.87+0.4, all P<0.001), this being the only lipid abnormality detected in the predialysis patients. In CAPD and HD patients, LDL scores were associated with serum triglyceride (r=0.81, P<0.001 and r=0.70, P<0.001 respectively), cholesterol (r=0.55, P<0.001 and r=0.49, P<0.01) and HDL-cholesterol (r= -0.43, P<0.01 and r= -0.51, P<0.01), whilst no such relationship was seen in the predialysis and RTR groups, suggesting that other factors were important.
CONCLUSIONS: The presence of small LDL particles appears to be an early and unexplained feature of the uraemic dyslipidaemia. This abnormality persists after renal transplantation and may represent an important atherogenic risk factor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761510     DOI: 10.1093/ndt/13.9.2281

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

Review 1.  Clinical assessment and management of dyslipidemia in patients with chronic kidney disease.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-06-22       Impact factor: 2.801

Review 2.  Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Clin Exp Nephrol       Date:  2013-08-24       Impact factor: 2.801

Review 3.  Lipoprotein metabolism and CKD: overview.

Authors:  Philip Barter
Journal:  Clin Exp Nephrol       Date:  2013-09-20       Impact factor: 2.801

4.  The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.

Authors:  J Lin; F B Hu; E B Rimm; N Rifai; G C Curhan
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

Review 5.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

6.  Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis.

Authors:  Ian H de Boer; Brad C Astor; Holly Kramer; Walter Palmas; Stephen L Seliger; Michael G Shlipak; David S Siscovick; Michael Y Tsai; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 8.237

7.  Dyslipidemia associated with chronic kidney disease.

Authors:  Vasilis Tsimihodimos; Zoi Mitrogianni; Moses Elisaf
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

8.  Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.

Authors:  Eiichiro Kanda; Masumi Ai; Mitsuyo Okazaki; Masayuki Yoshida; Yoshitaka Maeda
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

9.  Changes in serum pigment epithelium-derived factor levels after kidney transplantation in patients with end-stage renal disease.

Authors:  Réka Szentimrei; Hajnalka Lőrincz; Anita Szentpéteri; Viktória E Varga; Mariann Harangi; Ildikó Seres; Réka P Szabó; Balázs Nemes; György Paragh
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 10.  Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients.

Authors:  Anna Gluba-Brzozka; Beata Franczyk; Jacek Rysz
Journal:  Nutrients       Date:  2019-11-18       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.